Monoclonal Antibodies Mabs Market 2018-2026 Comprehensive Analysis on Key Player - Pfizer, Inc., GlaxoSmithKline PLC, Novartis AG, Merck & Co., Inc., Eli Lily & Co., AstraZeneca, Amgen, Inc., Abbott Laboratories

According to a new study published by Polaris Market Research, the global monoclonal antibodies (mAbs) market is anticipated to reach USD 148.9 Billion by 2026 growing at a CAGR of 6.1% during the forecast period.

Request for a sample of this research report @ https://www.polarismarketresearch.com/industry-analysis/global-monoclonal-antibodies-mabs-market/request-for-free-sample

An active pipeline is the major driving force behind the growth of the mAbs market. The surge in the prevalence of cancer and other chronic diseases, rising demand for personalized medicines, and the increasing awareness among medical professionals and patients about the latest medical therapies further augment the market growth. The other factors supplementing market growth include favorable government policies and increased research and development activities in the fields of biomedicine and genetic engineering among others. The growth of the mAbs market is limited by high costs of manufacturing, quality control and patient compliance, and mono-specificity of mAbs. On the other hand, newer therapeutic targets such as central nervous system, novel methods of drug delivery and price correction provide multiple opportunities for market growth.

The major players in the market include Pfizer, Inc., GlaxoSmithKline PLC, Novartis AG, Merck & Co., Inc., Eli Lily & Co., AstraZeneca, Amgen, Inc., Abbott Laboratories, Thermo Fisher Scientific, Inc., Bistro-Myers Squibb. Mylan N.V., Daiichi Sankyo Company, Ltd., Bayer AG, Hoffmann-La Roche Ltd., and Novo Nordisk A/S.

Browse Full Research Report with in-depth TOC @ https://www.polarismarketresearch.com/industry-analysis/global-monoclonal-antibodies-mabs-market/

In terms of geography, North America holds the major share of the global mAbs market. This report covers the following regions: North America, Europe, Asia-Pacific, Latin America and MEA. In terms of geography, North America accounted for the majority share in the global monoclonal antibodies market due to the presence of well-established healthcare infrastructure, whereas Latin America is anticipated to be the fastest growing region. This swelling growth is attributed to the relatively cheaper costs of labor and infrastructure, presence of major several market players in this region and rapidly increasing research and development activities.

Key Take-away

• Based on product type, fully human mAbs dominates the market in 2018.
• On the basis of Production System, the mammalian cell culture segment was the leading segment in terms of revenue and would continue to do so in the forecast period.
• Based on Indication, the cancer segment was leading segment in terms of revenue in 2017 and would continue to do so in the forecast period.
• The primary care segment holds the major share of the market share in 2017.

Make Inquiry about this report @ https://www.polarismarketresearch.com/industry-analysis/global-monoclonal-antibodies-mabs-market/inquire-before-buying

Market Segmentation

By Product Type

• Fully Human
• Murine
• Chimeric

By Production System

• Mammalian Cell Culture
• Microbial Fermentation

By Indication

• Cancer, Inflammation
• Cardiovascular diseases
• Transplant Rejection
• Respiratory
• Infectious diseases

By Technology Platforms

• Transgenic-Mouse
• Antibody Drug Conjugate
• Phage-Display

By Target Mechanism of Action

• CGRP
• HER2, CTLA4
• TNF alpha
• EGFR, VEGF
• Anti CD
• Anti IL
• IgGs
• PD-1/PD-L1

By Care Delivery Setting

• Primary Care
• Specialty Care

By Routes of Administration

• Subcutaneous
• Intravenous

By Drug Types

• Branded Biologics
• Biosimilars

By Geography

• North America

o U.S.
o Canada

• Europe

o UK
o Germany
o Spain

• Asia-Pacific

o China
o Japan
o India

• Latin America

o Brazil
o Mexico

• Middle East & Africa

Significant Note: Customized Research Report As per your Requirements: https://www.polarismarketresearch.com/industry-analysis/global-monoclonal-antibodies-mabs-market/request-for-customization

About Polaris Market Research

Polaris Market Research is a global market research and consulting company. The company specializes in providing exceptional market intelligence and in-depth business research services for our clientele spread across different enterprises. We at Polaris are obliged to serve our diverse customer base present across the industries of healthcare, technology, semi-conductors and chemicals among various other industries present around the world. We strive to provide our customers with updated information on innovative technologies, high growth markets, emerging business environments and latest business-centric applications, thereby helping them always to make informed decisions and leverage new opportunities. Adept with a highly competent, experienced and extremely qualified team of experts comprising SMEs, analysts and consultants, we at Polaris endeavor to deliver value-added business solutions to our customers.

Contact us

Mr. Neel
Corporate Sales, USA
Polaris Market Research
Phone: 1-646-568-9980
Email: neel@polarismarketresearch.com
Web: www.polarismarketresearch.com

This release was published on openPR.